Google Deepmind is shedding light on the dark genome with its latest AI model, which is trained to decipher the 98% of DNA ...
Zylox-Tonbridge Medical Technology Co. Ltd. plans to expand globally with M&As, company chairman and CEO Jonathon Zhong Zhao ...
Human respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) can cause severe and lethal bronchiolitis and ...
Tetrapharm (Tetra Pharm Technologies ApS) has announced promising preclinical data for TPC-026 for the chronic treatment and ...
Voltage-gated sodium channels, particularly Nav1.7, are highly expressed in peripheral sensory neurons and are crucial for ...
Samantree Medical SA is the latest med-tech company to secure financing from the European Investment Bank, highlighting the ...
Sensorion SA has announced a €60 million (US$72 million) financing, with a €20 million (US$24 million) strategic investment ...
The serine/threonine kinase glycogen synthase kinase-3β (GSK-3β) plays a multifunctional role through its involvement in ...
With the PDUFA date fast approaching for Regenxbio Inc.’s gene therapy RGX-121, the U.S. FDA placed the drug on clinical hold ...
The pressure on U.S. drug prices continues, with the CMS lining up the drugs for round 3 of negotiations, which will set ...
Third-party litigation funding in Europe has created enough of a stir that several trade associations issued a joint statement making the case that the unregulated nature of these funding agreements ...
Boehringer Ingelheim International GmbH signed a €1.058 billion (US$1.26 billion) deal with Simcere Pharmaceutical Group Ltd. to license select rights to SIM-0709, a preclinical TL1A/IL-23p19-directed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results